Search research articles
Contact Us
Filters
Showing results (161-170 of 185) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines
Franz O Smith, Stephanie G Downey, Jacob A Klapper, et al.
Annals of the American Thoracic Society
|
December 22, 2022
Clinimetric Properties of Outcome Measures in Bronchiectasis
Judy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 20, 2021
Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis
J Stuart Elborn, Michael W Konstan, Jennifer L Taylor-Cousar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2007
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
Stephanie G Downey, Jacob A Klapper, Franz O Smith, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 29, 2023
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment
Gisli G Einarsson, Laura J Sherrard, Joseph E Hatch, et al.
The Lancet. Respiratory Medicine
|
December 23, 2021
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial
Sivagurunathan Sutharsan, Edward F McKone, Damian G Downey, et al.
The Lancet. Respiratory Medicine
|
February 13, 2021
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
Patrick A Flume, Reta Fischer Biner, Damian G Downey, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
May 14, 2025
Managing an ageing cystic fibrosis population: challenges and priorities
Freddy J Frost, Daniel G Peckham, Imogen C Felton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 22, 2021
Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis
Nico Derichs, Jennifer L Taylor-Cousar, Jane C Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
Mark E Dudley, James C Yang, Richard Sherry, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 185) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 4, 2008
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines
Franz O Smith, Stephanie G Downey, Jacob A Klapper, et al.
Annals of the American Thoracic Society
|
December 22, 2022
Clinimetric Properties of Outcome Measures in Bronchiectasis
Judy M Bradley, Kathryn Ferguson, Andrew Bailey, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 20, 2021
Empire-CF study: A phase 2 clinical trial of leukotriene A4 hydrolase inhibitor acebilustat in adult subjects with cystic fibrosis
J Stuart Elborn, Michael W Konstan, Jennifer L Taylor-Cousar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2007
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
Stephanie G Downey, Jacob A Klapper, Franz O Smith, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
December 29, 2023
Longitudinal changes in the cystic fibrosis airway microbiota with time and treatment
Gisli G Einarsson, Laura J Sherrard, Joseph E Hatch, et al.
The Lancet. Respiratory Medicine
|
December 23, 2021
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial
Sivagurunathan Sutharsan, Edward F McKone, Damian G Downey, et al.
The Lancet. Respiratory Medicine
|
February 13, 2021
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
Patrick A Flume, Reta Fischer Biner, Damian G Downey, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
May 14, 2025
Managing an ageing cystic fibrosis population: challenges and priorities
Freddy J Frost, Daniel G Peckham, Imogen C Felton, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
August 22, 2021
Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis
Nico Derichs, Jennifer L Taylor-Cousar, Jane C Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
Mark E Dudley, James C Yang, Richard Sherry, et al.
Page
of 19